Literature DB >> 15858415

Decrease in NF-kappaB, AP-1 and SP-1 activities in neuronal cells expressing presenilin 2.

Hong Nga Nguyen1, Sun Young Lee, Dae Youn Hwang, Yong Kyu Kim, Dong Yeon Yuk, Jun Seup Lee, Jin Tae Hong.   

Abstract

Decreases in activities of the NF-kappaB, AP-1 and SP-1 transcription factors, which could act as antiapoptotic factors, in the presenilin 2 transfected PC12 cells, either in nontreatment conditions or under apoptotic stimulation, were found in this study. Similar results were also found in mice brain cells carrying presenilin 2, especially in the mutant gene expressed ones. These findings suggested that presenilin 2 may be implicated in neuronal cell death by altering the antiapoptotic activity of the transcription factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858415     DOI: 10.1097/00001756-200505120-00015

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Presenilin 2 influences miR146 level and activity in microglia.

Authors:  Suman Jayadev; Amanda Case; Betty Alajajian; Alison J Eastman; Thomas Möller; Gwenn A Garden
Journal:  J Neurochem       Date:  2013-09-30       Impact factor: 5.372

2.  p53-dependent control of transactivation of the Pen2 promoter by presenilins.

Authors:  Julie Dunys; Jean Sevalle; Emilie Giaime; Raphaëlle Pardossi-Piquard; Michael P Vitek; Paul Renbaum; Ephrat Levy-Lahad; Yun-wu Zhang; Huaxi Xu; Frédéric Checler; Cristine Alves da Costa
Journal:  J Cell Sci       Date:  2009-11-01       Impact factor: 5.285

3.  Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Authors:  Bryan Maloney; Yuan-Wen Ge; Ronald C Petersen; John Hardy; Jack T Rogers; Jordi Pérez-Tur; Debomoy K Lahiri
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.